Condition: Kidney Rejection Transplant · Sponsor: Paris Translational Research Center for Organ Transplantation
Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better understand the pathophysiological mechanisms associated with the various phenotypes of microvascular inflammation that are observed in kidney transplants, particularly in order to develop targeted therapeutic approaches.
This description comes directly from the study's public registry record.
Alexandre Loupy, MD PhD · +33612491082 · alexandreloupy@inserm.fr
Catherine Tritscher · +33153988000 · tritschercatherine@gmail.com
Always discuss trial participation with your own doctor first.
| Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris | Paris, France | Recruiting |
| Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris | Paris, France | Recruiting |
| Bichat Hospital, Assistance Publique - Hôpitaux de Paris | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06342128